Professor | Hao Bao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Hao Bao
Contact Information	bhao@nju.edu.cn
Language ability	English, Chinese
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Hao Bao

Contact Information

bhao@nju.edu.cn

Language ability

English, Chinese

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	2008: Graduated from Nanjing University Medical School with a combined bachelor's, master's, and doctoral degree in Internal Medicine 2010-2011: Visiting Scholar at Brown University Medical School Selected for Jiangsu Province 'Six Talent Peaks' and Nanjing University 'Top Talent Support Program'
Work Experience	2009-present: Working at the Department of Nephrology, Eastern Theater General Hospital Current: Associate Chief Physician at the Department of Nephrology, Eastern Theater General Hospital Current: Associate Professor and Doctoral Supervisor at Nanjing University Medical School
Awards	2015: First Prize of Military Medical Achievement Award for new techniques in clinical diagnosis and treatment of kidney diseases 2016: First Prize of Chinese Medical Science and Technology Award for new techniques in the diagnosis and treatment of lupus nephritis and IgA nephropathy 2020: Second Prize of National Science and Technology Progress Award for innovation and application of strategies and key technologies in the diagnosis and treatment of glomerulonephritis

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

2008: Graduated from Nanjing University Medical School with a combined bachelor's, master's, and doctoral degree in Internal Medicine
2010-2011: Visiting Scholar at Brown University Medical School
Selected for Jiangsu Province 'Six Talent Peaks' and Nanjing University 'Top Talent Support Program'

Work Experience

2009-present: Working at the Department of Nephrology, Eastern Theater General Hospital
Current: Associate Chief Physician at the Department of Nephrology, Eastern Theater General Hospital
Current: Associate Professor and Doctoral Supervisor at Nanjing University Medical School

Awards

2015: First Prize of Military Medical Achievement Award for new techniques in clinical diagnosis and treatment of kidney diseases
2016: First Prize of Chinese Medical Science and Technology Award for new techniques in the diagnosis and treatment of lupus nephritis and IgA nephropathy
2020: Second Prize of National Science and Technology Progress Award for innovation and application of strategies and key technologies in the diagnosis and treatment of glomerulonephritis

Areas of Focus	Clinical and basic research on podocyte diseases Mechanism and intervention research of IgA nephropathy Clinical drug and alternative treatment for chronic kidney disease Biomaterials and kidney diseases
Publications	Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes, Hu S, Han R, Chen L, Qin W, Xu X, Shi J, Zhu X, Zhang M, Zeng C, Tang Z, Bao H, Liu Z, 2021 C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis, Han R, Hu S, Qin W, Shi J, Hou Q, Wang X, Xu X, Zhang M, Zeng C, Liu Z, Bao H, 2019 Upregulated long noncoding RNA LOC105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis, Han R, Hu S, Qin W, Shi J, Zeng C, Bao H, Liu Z, 2019 The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis, Hu S, Han R, Shi J, Zhu X, Qin W, Zeng C, Bao H, Liu Z, 2018 Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA associated GN, Chen Y#, Bao H#, Liu Z, Liu X, Gao E, Zeng C, Zhang H, Liu Z, Hu W, 2017 Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution, Bao H, Chen H, Zhu X, Xu F, Zhu M, Zhang M, He Q, Zeng C, Liu Z, 2015 MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin alpha4 and alpha5 in IgA nephropathy, Bao H, Chen H, Zhu X, Zhang M, Yao G, Yu Y, Qin W, Zeng C, Zen K, Liu Z, 2014

Areas of Focus

Clinical and basic research on podocyte diseases
Mechanism and intervention research of IgA nephropathy
Clinical drug and alternative treatment for chronic kidney disease
Biomaterials and kidney diseases

Publications

Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes, Hu S, Han R, Chen L, Qin W, Xu X, Shi J, Zhu X, Zhang M, Zeng C, Tang Z, Bao H*, Liu Z*, 2021
C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis, Han R, Hu S, Qin W, Shi J, Hou Q, Wang X, Xu X, Zhang M, Zeng C, Liu Z*, Bao H*, 2019
Upregulated long noncoding RNA LOC105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis, Han R, Hu S, Qin W, Shi J, Zeng C, Bao H*, Liu Z*, 2019
The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis, Hu S, Han R, Shi J, Zhu X, Qin W, Zeng C, Bao H*, Liu Z*, 2018
Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA associated GN, Chen Y#, Bao H#, Liu Z, Liu X, Gao E, Zeng C, Zhang H, Liu Z, Hu W, 2017
Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution, Bao H, Chen H, Zhu X, Xu F, Zhu M, Zhang M, He Q, Zeng C, Liu Z, 2015
MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin alpha4 and alpha5 in IgA nephropathy, Bao H, Chen H, Zhu X, Zhang M, Yao G, Yu Y, Qin W, Zeng C, Zen K, Liu Z, 2014

Podocyte Diseases Clinical Research Basic Research Iga Nephropathy Mechanism Intervention Chronic Kidney Disease Clinical Drug Alternative Treatment Biomaterials

Xianlong Zhou - Wuhan University

Jing Chen - Wuhan University

Hongxin Xu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us